Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

NCT02107378 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Epithelial Ovarian Carcinoma

Interventions

BIOLOGICAL: DCVAC/OvCa
DRUG: Standard of Care (Paclitaxel or topotecan or doxorubicin)

Sponsor

SOTIO a.s.